AlphAIAlphAI — Financial news for AI agents
SEC EDGAROCT 81 min read$ARQQ

Wilder Ben Simon sold $5K of ARQQ

Wilder Ben Simon (Chief Operating Officer) sold 218 shares of Arqit Quantum Inc. (ARQQ) at $24.19 on 2026-10-06.

Original reporting
SEC EDGAR · Wilder Ben Simon
Published Oct 8, 2026, 10:19 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 8, 2026, 10:21 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$ARQQ
Neutral
high confidence
Mentioned
$ARQQ
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ARQQNeutralLow
01

Why it matters

The disclosed sale is small and unlikely to move the stock significantly, but it provides transparency for investors monitoring insider activity.

02

Market read

A routine insider sale with limited market impact; primarily of interest to shareholders tracking insider activity.

03

What to watch

Potential tax‑loss harvesting or portfolio rebalancing could be motives unrelated to company outlook.

Relevance 3/10Novelty 3/10Timing: post-market filing on Oct 8

Background

Form 4 filings disclose insider transactions and are primary sources for such events.

Company-level read

Ticker impact

$ARQQNeutralHigh confidence
Context

COO Wilder Ben Simon sold 218 shares for $5,273.75 in a Form 4 filing.

Expected impact

likely modest downward pressure as the market prices the insider sale

Evidence & confidence

The sale is small relative to holdings and represents a routine transaction with no broader strategic implication.

Market effects

Sector

None; the transaction is company‑specific and does not affect the broader quantum technology sector.

Regional

None; the filing is a routine US SEC disclosure.

Global

Minimal; only relevant to ARQQ shareholders.

Counterpoint

What could challenge this read

The sale could be interpreted as a lack of confidence, but the size is negligible and may not reflect insider sentiment.

Key entities

  • Company
    Arqit Quantum Inc.

    Quantum communications firm listed on Nasdaq under ARQQ.

  • Person
    Wilder Ben Simon

    Chief Operating Officer of Arqit Quantum.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

ARQQ insider trading history →

Related articles

JUN 4
$QNTMedAI 9/10

Quantum Computing Shares Sink Ahead Of Blockbuster Quantinuum IPO

Quantinuum (QNT) shares fell Wednesday as the Honeywell-backed firm neared its Nasdaq debut, with pricing set for June 3 and first trading expected June 4. The company plans to sell 26.5 million shares at $53–$55 to raise about $1.46 billion, valuing it at up to $14.3 billion, according to the report. Other quantum stocks also declined.

finance.yahoo.com4 min
OCT 27
$LYCAMedAI 8/10

Venrock Healthcare Capital Partners III, L.P. (Koh Bong Y, Shah Nimish P) purchased $37.7M of LYCA (indirect holdings)

Venrock Healthcare Capital Partners III, L.P. purchased 2,045,440 indirectly-held shares of Lycia Therapeutics, Inc. (LYCA) at an average of $18.41 ($18.00–$26.97, $37.65M total) across 6 trades over 2026-10-23 to 2026-10-27. Filed jointly with VHCP Co-Investment Holdings III, LLC (10% owner), VHCP Management III, LLC (10% owner), Venrock Healthcare Capital Partners EG, L.P. (10% owner), VHCP Management EG, LLC (10% owner), Venrock Healthcare Capital Partners XP, L.P. (10% owner), VHCP Management XP, LLC (10% owner), Koh Bong Y (10% owner) and Shah Nimish P (10% owner).

SEC EDGAR1 min